Friday, November 22, 2024
11/22/2024
Project Summary/Abstract Loss of vision has a devastating impact on an individual's quality of life. Most blinding diseases result from loss of neurons in the retina. A promising strategy to treat sight-threatening diseases, is to harness the regenerative potential of cells within the retina. Müller glia (MG), possess an extraordinary capacity in lower vertebrates to regenerate retinal neurons. However, in mammalian retinas, including humans, MG are unable to replace neurons lost to injury or disease. Recently, we have developed strategies to neurogenically reprogram MG in adult mice by overexpressing the transcription factor Ascl1 in MG. Remarkably, the treatment of Ascl1 overexpression, combined with NMDA-induced retinal damage and histone deacetylase (HDAC) inhibition, causes MG to regenerate functional neurons in the adult mammalian retina. While this is significant progress towards realizing the therapeutic potential of MG, only a subset of MG successfully reprogram into neurogenic progenitors while another subset of MG express genes associated with inflammatory processes. We hypothesized that the inflammation that accompanies neuronal cell loss restricts the regenerative potential of MG. Indeed, we recently found that ablation of microglia, the endogenous immune cell of the retina, dramatically improved MG-mediated retinal regeneration. This finding implicates the neuroimmune system as a key component of the regenerative response of the mammalian retina. However, little is known about the neuroimmune interface in retinal repair strategies such as endogenous regeneration. This proposal outlines studies to better understand the neuroimmune axis during MG-mediated retinal regeneration and to develop immunomodulation strategies to improve the regenerative capacity of the mammalian retina. The data generated in this proposal will be foundational to Dr. Todd's ultimate goal of becoming an independent investigator. During the K99 portion, Dr. Todd will expand his technical and theoretical expertise in neuroimmunology to accomplish his aims studying immune-glial interactions during retinal regeneration. New collaborations will be established with investigators in neuroimmunology and further training activities will prepare Dr. Todd to become a successful investigator in the field. The training portion of this proposal will take place at the University of Washington, which offers exceptional access to both research equipment and faculty expertise to assist in the accomplishment of the applicant's goals.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
